Title : Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion - Kalra_2014_Cancer.Res_74_7003 |
Author(s) : Kalra AV , Kim J , Klinz SG , Paz N , Cain J , Drummond DC , Nielsen UB , Fitzgerald JB |
Ref : Cancer Research , 74 :7003 , 2014 |
Abstract : Kalra_2014_Cancer.Res_74_7003 |
ESTHER : Kalra_2014_Cancer.Res_74_7003 |
PubMedSearch : Kalra_2014_Cancer.Res_74_7003 |
PubMedID: 25273092 |
Kalra AV, Kim J, Klinz SG, Paz N, Cain J, Drummond DC, Nielsen UB, Fitzgerald JB (2014)
Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion
Cancer Research
74 :7003
Kalra AV, Kim J, Klinz SG, Paz N, Cain J, Drummond DC, Nielsen UB, Fitzgerald JB (2014)
Cancer Research
74 :7003